TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Takara Bio Europe AB
Closing information (x1000 DKK)
Closing information | 2020/12 | 2019/12 | 2018/12 |
Turnover |
22,590
|
28,939
|
29,394 |
Financial expenses |
812
|
644
|
1,213 |
Earnings before taxes |
-4,435
|
-6,299
|
-8,281 |
EBITDA |
-3,278
|
-5,431
|
-6,572 |
Total assets |
33,332
|
24,045
|
29,998 |
Current assets |
16,482
|
15,412
|
20,768 |
Current liabilities |
5,720
|
4,470
|
7,094 |
Equity capital |
20,454
|
12,721
|
6,986 |
- share capital |
1,647
|
1,591
|
1,615 |
Employees (average) |
28
|
26
|
27 |
Financial ratios
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Solvency |
61.4%
|
52.9%
|
23.3% |
Turnover per employee |
807
|
1,113
|
1,089 |
Profit as a percentage of turnover |
-19.6%
|
-21.8%
|
-28.2% |
Return on assets (ROA) |
-10.9%
|
-23.5%
|
-23.6% |
Current ratio |
288.1%
|
344.8%
|
292.8% |
Return on equity (ROE) |
-21.7%
|
-49.5%
|
-118.5% |
Change turnover |
-7,369
|
-18
|
750 |
Change turnover % |
-25%
|
0%
|
3% |
Chg. No. of employees |
2
|
-1
|
-4 |
Chg. No. of employees % |
8%
|
-4%
|
-13% |
Total value of public sale
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.